Aaron Wininger is a Principal and Schwegman’s Director of China Intellectual Property. Aaron counsels both U.S. and Chinese companies on portfolio development and preparation of their patent applications and office action responses. He has worked with clients in the areas of software, networks (wired and wireless), lasers, medical devices, semiconductors and physics.
Aaron prosecutes both Chinese and U.S. trademarks. He has also drafted and prosecuted hundreds of U.S. and international patent applications in a broad spectrum of areas, including computer hardware and software, the Internet, multimedia distribution systems, computer games, digital and analog circuitry, and semiconductor design and fabrication, to name a few.
Most recently, Aaron has counseled Chinese companies on freedom to operate analyses for their entry into the U.S., represented a U.S. gaming company with operations in China, handling Series A and IP issues in China through to IPO; a U.S. scanning electron microscope company, handling their patent portfolio from incorporation through exit via acquisition, and a U.S. wireless company through acquisition. His knowledge of both the Chinese and American markets allows him to advise his clients as they expand their patent portfolios and look for investors to help the company grow.
Aaron has been in China for more than a decade and is conversational in Mandarin.
More Legal and Business Bylines From Aaron Wininger
- Forbidden: China Again Geo-Blocking Supreme People’s Court Website - (Posted On Wednesday, September 20, 2023)
- China’s Supreme People’s Court Releases 2023 People’s Courts Typical Anti-Monopoly and Anti-Unfair Competition Cases - (Posted On Friday, September 15, 2023)
- China’s Supreme People’s Court Again Affirms Right to Set Global Licensing Rates for Standard Essential Patents - (Posted On Tuesday, September 12, 2023)
- Belgian Artist Christian Silvain Wins Copyright Suit Against Sichuan Academy of Fine Arts Professor at Beijing IP Court - (Posted On Friday, September 08, 2023)
- China’s National Intellectual Property Administration Releases Typical Cases of Abnormal Patent Applications - (Posted On Wednesday, September 06, 2023)
- China’s National Intellectual Property Administration Releases Guidelines for Delayed Examination of Invention Patent Applications - (Posted On Friday, September 01, 2023)
- China’s National Intellectual Property Administration Releases the “2023 Outline for Building a Powerful Intellectual Property Country and Implementation Promotion Plan of the 14th Five-Year Plan” - (Posted On Sunday, July 30, 2023)
- 15 Rolex Counterfeiters Sentenced to up to 6.5 Years Prison in 300 Million RMB Counterfeit Case - (Posted On Tuesday, July 25, 2023)
- China’s State Administration for Market Regulation Releases Draft Anti-monopoly Guidelines in the Field of Standard Essential Patents for Comment - (Posted On Thursday, July 20, 2023)
- China’s Utility Model Grants Down 25% in First Half of 2023; Invention Patent Grants Up 10% - (Posted On Tuesday, July 18, 2023)
Aaron Wininger of Schwegman, Lundberg & Woessner, P.A. is a 2022 National Law Review Go-To Thought Leader. Mr. Wininger covers the patent law and intellectual property landscape in China, detailing matters such as trade secret theft, major intellectual property court rulings, and the ongoing issue of counterfeit products. These topics have seen considerable readership throughout the year, demonstrating the high value of Mr. Wininger’s thought leadership.
Aaron Wininger, Schwegman’s Director of China Intellectual Property law, is a National Law Review Go-To Thought Leader for his contributions focusing on Chinese Intellectual Property Regulation, Legislation, and Litigation. Mr. Wininger’s experience counseling both U.S. and Chinese companies on portfolio development, preparation of patent applications and office action responses and his familiarity with the China National Intellectual Property Administration (CNIPA) adds to his timely analysis of Chinese trademark, patent, and copyright cases and what they mean for companies in both the U.S and in the People’s Republic of China.